BCWorldPharm Co Ltd banner
B

BCWorldPharm Co Ltd
KOSDAQ:200780

Watchlist Manager
BCWorldPharm Co Ltd
KOSDAQ:200780
Watchlist
Price: 4 520 KRW 0.89%
Market Cap: ₩48.2B

Balance Sheet

Balance Sheet Decomposition
BCWorldPharm Co Ltd

Balance Sheet
BCWorldPharm Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
605
544
217
25 079
4 255
1 221
3 841
2 393
1 686
10 681
2 756
4 032
6 996
5 444
5 884
Cash
0
0
4
4
2
1
2
2
1
1
2
1
1
1
0
Cash Equivalents
605
544
213
25 075
4 253
1 220
3 839
2 391
1 685
10 680
2 754
4 031
6 995
5 444
5 883
Short-Term Investments
1 656
5 870
4 195
1 154
1 154
1 394
1 380
2 380
1 770
1 880
1 746
4 025
4 170
2 467
927
Total Receivables
13 323
11 106
12 932
14 306
15 775
19 602
21 097
21 065
16 142
14 722
15 942
17 778
19 483
20 914
20 292
Accounts Receivables
12 992
10 820
12 538
13 895
15 171
19 053
20 318
20 320
15 448
13 895
15 050
16 557
18 269
20 339
18 743
Other Receivables
331
286
394
411
604
549
779
745
694
827
892
1 221
1 214
575
1 548
Inventory
6 382
7 097
7 710
8 402
8 718
12 705
14 343
18 684
23 473
26 000
16 147
16 787
17 096
14 844
21 306
Other Current Assets
4 340
143
1 602
1 637
412
583
286
1 783
240
411
643
986
341
889
667
Total Current Assets
26 305
24 760
26 657
50 578
30 315
35 506
40 948
46 306
43 311
53 693
37 235
43 609
48 086
44 558
49 075
PP&E Net
10 414
10 838
12 933
21 614
45 402
56 140
72 840
109 727
122 881
130 908
132 370
130 119
125 628
120 985
117 852
PP&E Gross
10 414
10 838
12 933
21 614
45 402
56 140
72 840
109 727
0
0
0
0
0
0
117 852
Accumulated Depreciation
4 733
5 801
6 833
8 055
9 274
11 041
13 577
15 991
0
0
0
0
0
0
4 818
Intangible Assets
1 083
1 203
1 310
1 349
1 310
1 375
1 411
1 699
1 296
1 175
2 266
2 828
2 997
2 711
2 544
Long-Term Investments
251
321
54
54
504
504
404
1 699
1 994
3 303
3 756
1 362
1 784
2 921
2 616
Other Long-Term Assets
702
1 483
1 466
1 240
1 826
2 896
2 739
2 308
3 295
3 885
3 732
5 133
5 616
5 139
4 715
Total Assets
38 755
N/A
38 604
0%
42 419
+10%
74 835
+76%
79 356
+6%
96 420
+22%
118 341
+23%
161 739
+37%
172 776
+7%
192 964
+12%
179 358
-7%
183 051
+2%
184 111
+1%
176 313
-4%
176 801
+0%
Liabilities
Accounts Payable
2 735
1 913
2 801
4 026
4 814
6 571
5 940
4 512
6 118
4 106
2 686
4 067
4 232
3 872
7 732
Accrued Liabilities
1 296
1 217
1 425
1 361
476
538
767
426
425
387
638
1 255
1 300
4 632
4 817
Short-Term Debt
5 800
1 700
1 700
2 763
2 050
2 050
6 550
7 130
13 240
26 550
30 100
35 550
46 980
56 680
50 820
Current Portion of Long-Term Debt
5 226
5 612
7 213
1 374
4
421
2 744
3 753
9 893
17 090
15 102
37 380
32 866
17 836
21 777
Other Current Liabilities
2 215
1 063
1 438
1 158
3 511
3 258
3 418
16 972
11 084
7 384
7 367
5 954
6 869
2 844
4 567
Total Current Liabilities
17 272
11 506
14 577
10 682
10 855
12 838
19 419
32 794
40 760
55 518
55 892
84 206
92 246
85 865
89 713
Long-Term Debt
1 910
4 108
1 922
1 855
1 100
9 706
17 461
38 650
34 754
32 698
43 819
21 325
11 995
14 438
14 567
Deferred Income Tax
4
0
0
588
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
0
0
0
0
0
0
233
207
21
1 446
1 811
2 032
1 774
657
1 221
Other Liabilities
304
321
0
0
0
0
0
0
0
4 500
0
0
0
0
19
Total Liabilities
19 490
N/A
15 935
-18%
16 498
+4%
13 125
-20%
11 955
-9%
22 544
+89%
37 113
+65%
71 651
+93%
75 535
+5%
91 270
+21%
97 901
+7%
103 499
+6%
102 468
-1%
99 645
-3%
105 521
+6%
Equity
Common Stock
830
830
830
1 335
1 335
1 335
1 462
1 602
1 602
1 778
1 778
1 778
1 778
1 778
1 947
Retained Earnings
17 896
20 960
24 212
27 871
33 562
40 037
47 350
55 180
60 461
65 639
45 255
44 404
46 495
41 520
35 912
Additional Paid In Capital
879
879
0
31 846
31 846
31 846
31 846
31 846
31 846
34 068
34 068
34 068
34 068
34 068
34 068
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
853
955
101
249
0
0
0
0
Treasury Stock
0
0
0
220
220
220
241
272
747
772
772
807
0
0
0
Other Equity
340
0
879
879
879
879
811
879
3 125
879
879
107
699
699
647
Total Equity
19 265
N/A
22 669
+18%
25 921
+14%
61 710
+138%
67 401
+9%
73 876
+10%
81 228
+10%
90 088
+11%
97 241
+8%
101 694
+5%
81 458
-20%
79 552
-2%
81 643
+3%
76 668
-6%
71 281
-7%
Total Liabilities & Equity
38 755
N/A
38 604
0%
42 419
+10%
74 835
+76%
79 356
+6%
96 420
+22%
118 341
+23%
161 739
+37%
172 776
+7%
192 964
+12%
179 358
-7%
183 051
+2%
184 111
+1%
176 313
-4%
176 801
+0%
Shares Outstanding
Common Shares Outstanding
7
7
7
10
10
9
10
10
10
10
10
10
10
10
9
Preferred Shares Outstanding
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett